HOME >> BIOLOGY >> NEWS
Bioprocesses upstage traditional chemical processes

Palo Alto, Calif. -- March 9, 2004 Exciting advances in biotechnology are driving the increasing acceptance of biotech products in several industries, especially pharmaceuticals, agriculture, and chemicals. Bioprocesses sometimes eliminate conventional steps in chemical synthesis while enabling cost-effective manufacturing.

"The pace of bioprocess adoption in different industries will depend on the economic viability of the process and the influence of regulations," says Technical Insights Analyst Miriam Nagel. "Additionally, the difficulties associated with biotech adoption are likely to vary and concerns of one industry may not be significant for another industry."

For instance, intensity and high cost of R&D is expected to weigh down the development of biopharmaceutical drugs, whereas political uncertainties and public pressure for safe and sustainable development are critical factors in the chemicals industry.

Agriculture will be another key sector confronting two primary challenges -- public apprehension over genetic engineering processes and the subsequent enactment of complex regulations. These factors are likely to slow down the adoption of bioprocesses.

However, if the launch of blockbuster biopharmaceutical drugs for hepatitis, cancer, diabetes, and hemophilia, and the subsequent revenue surge for pharmaceutical companies in 2003, is any indication, more industries are likely to step up the deployment of bioprocesses.

"The elimination of several conventional steps used to synthesize vitamins and antibiotics has significantly reduced production cost and adverse impact on the environment, and this, in turn, is encouraging the acceptance of bioprocesses," says Nagel.

The gradual increase in adoption rate is distinctly evident from the development of biopolymers particularly biodegradable plastics derived entirely from renewable resources, and introduction of applications such as biodegradable cutlery and disp
'"/>

Contact: Julia Paulson
jpaulson@frost.com
210-247-3870
Technical Insights
8-Mar-2004


Page: 1 2 3

Related biology news :

1. Virtual counselor supplements traditional genetic counseling
2. Changing focus of traditional hospital rounds improves patient care
3. Experimental microbeam radiation therapy may offer improvement over traditional radiation treatments
4. ASTA calls for global standards of tolerance for adventitious presence biotech material in traditional seed
5. Colorado State researcher thinks Groundhog Day is about fatty acids rather than traditional tricks of light and shadow
6. Common parasite overturns traditional beliefs about the evolution and role of hemoglobin
7. DNA lends scientists a hand, revealing new chemical reactions
8. Grant advances biochemical engineering laboratory
9. Bullish chemical could repel yellow fever mosquitoes
10. Computer database being developed at Temple will allow for better inventory of chemicals
11. Cleaner water, more efficient electricity among UH chemical research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... (PRWEB) , ... May 20, 2020 , ... ... and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health ... & Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, ...
(Date:5/15/2020)... FREDERICK, Md. (PRWEB) , ... May 15, 2020 , ... ... a boutique intellectual property law firm based in Frederick, Maryland and Tysons Corner, Virginia, ... the field of biotechnology and a another in the field of chemistry. The firm ...
(Date:5/14/2020)... ALPHARETTA, Ga. (PRWEB) , ... May 14, 2020 ... ... ), a job board for medical sales representatives, found the 2019 average medical ... encouraging 2020 findings risk being shadowed by uncertainties amid the COVID-19 global crisis. ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... (PRWEB) , ... May 14, 2020 , ... This new ... unforeseen and the most pressing questions answered quickly as the need arises. Lachman’s OnCall ... offering valuable advice at affordable rates. , Lachman OnCall™ SMEs are available normal ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of ... little or no information on the drug’s mechanism of action (MOA). Gene expression ... by measuring the activity of molecular pathways. This information can complement phenotypic readouts ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... today, honoring the businesses, policies, projects, and concepts that are actively engaged and ... for living cells, which has taken out the top prize in the Experimental ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... continue their work through COVID-19. Many clinical trial teams are working remotely and ... Ripple Science wants to help researchers continue their research during this uncertain time ...
Breaking Biology Technology:
Cached News: